Introduction Cervical cancer is the leading cause of cancer deaths in women in the
developing world. New technologies have been developed to allow for more rapid, cost …

Introduction The WHO recommends human papillomavirus (HPV) cervical self-sampling as
an additional screening method and HPV DNA testing as an effective approach for the early …

Abstract The American Cancer Society (ACS) recommends that individuals with a cervix
initiate cervical cancer screening at age 25 years and undergo primary human …

Cervical cancer (CC) represents the fourth most common malignancy affecting women all
over the world and is the second most common in developing areas. In these areas, the …

Context Human papillomavirus (HPV) infection is estimated to be the most common sexually
transmitted infection. Baseline population prevalence data for HPV infection in the United …

In most industrialized countries, screening programs for cervical cancer have shifted from
cytology (Pap smear or ThinPrep) alone on clinician-obtained samples to the addition of …

Objective To provide a focused critical review of the literature on the acceptability, feasibility,
and uptake of human papillomavirus (HPV) self-sampling among hard-to-reach women …

Objectives A meta-analysis was conducted to examine the effectiveness of HPV self-
sampling proposal on cervical cancer screening (CCS) uptake when compared with an …

Background Vaginal self-sampling for human papillomavirus (HPV) DNA testing could
increase rates of screening participation. In clinic-based settings, vaginal HPV testing is at …

Background Vaginal self-sampling with HPV-DNA tests is a promising primary screening
method for cervical cancer. However, women's experiences, concerns and the acceptability …